Faster, More Frequent Proteinuria Reduction With Sparsentan in FSGS

Watchdoq April 14, 2025
(MedPage Today) -- BOSTON -- Patients with focal segmental glomerulosclerosis (FSGS) achieved some degree of proteinuria remission more often and more quickly on sparsentan (Filspari) than irbesartan (Avapro), secondary analyses of the phase...

Read Full Article